Cite
HARVARD Citation
Lefrère, F. et al. (2013). Impact of rituximab on stem cell mobilization following ACVBP regimen in poor‐risk patients with diffuse large B‐cell lymphoma: results from a large cohort of patients. Transfusion. 53 (1), pp. 115-122. [Online].